InvestorsHub Logo
Followers 128
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: None

Monday, 03/29/2021 1:47:01 PM

Monday, March 29, 2021 1:47:01 PM

Post# of 200344
Additionally, the Company has entered negotiations with Pro Wave Ad Product ("PWA"), a Bulgarian Company, to supply the raw material for PWA's Contract in India for the production of a spray modulating the immune system under U.S. Patent No. 8,309,072 owned by Zhabilov Trust. This contract is valued at more than $50 million to PWA. This is the only approved use of this technology as a nutraceutical. The FDA issued a nutraceutical number to Harry Zhabilov on October 12, 2018. The first delivery under this agreement with PWA is expected to be in late spring 2021. The value to the Company is yet to be determined.